Emma Kerklingh
Associate Director Business Development Scinus Cell Expansion
Emma Kerklingh is Associate Director Business Development at Scinus Cell Expansion, where she is involved in strategic commercial engagement for Osilaris™ across cell therapy development, clinical manufacturing and CDMO partnerships. Her work focuses on aligning controlled, bioreactor-based expansion technologies with the practical requirements of advanced therapy process development, including scalability, process robustness and manufacturability.
Seminars
Wednesday 15th July 2026
Osilaris™ for Controlled, Scalable Cell Expansion: Supporting Process Robustness from Development to Manufacturing
11:30 am
- Addressing the limitations of conventional 2D expansion workflows when cell therapy processes need to move towards closed, scalable and reproducible manufacturing
- Exploring how Osilaris™ supports controlled low-shear expansion with in-line process control to help maintain process-relevant quality attributes
- Discussing how automation-ready bioreactor processing can support clinical-to-commercial progression, decentralised manufacturing models and lower process variability
